|
ADAM10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.673800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.390200E-01 |
| Normal-vs-Stage2 |
2.330200E-01 |
| Normal-vs-Stage3 |
5.538500E-03 |
| Normal-vs-Stage4 |
8.401400E-03 |
| Stage1-vs-Stage2 |
4.796400E-01 |
| Stage1-vs-Stage3 |
1.383620E-03 |
| Stage1-vs-Stage4 |
4.863100E-03 |
| Stage2-vs-Stage3 |
1.542960E-01 |
| Stage2-vs-Stage4 |
1.914240E-01 |
| Stage3-vs-Stage4 |
9.406000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.095600E-02 |
| Normal-vs-AfricanAmerican |
4.692500E-02 |
| Normal-vs-Asian |
4.121400E-01 |
| Caucasian-vs-AfricanAmerican |
3.847200E-01 |
| Caucasian-vs-Asian |
5.671800E-02 |
| AfricanAmerican-vs-Asian |
5.304400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.347700E-02 |
| Normal-vs-Female |
9.221700E-02 |
| Male-vs-Female |
7.242000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.677800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.475840E-01 |
| Normal-vs-Age(61-80Yrs) |
3.627900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.008300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.286200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.365600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.603600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.472200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.116030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.344400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.301400E-01 |
| Normal-vs-Grade 2 |
3.444400E-01 |
| Normal-vs-Grade 3 |
2.447600E-02 |
| Normal-vs-Grade 4 |
1.440660E-03 |
| Grade 1-vs-Grade 2 |
1.701390E-01 |
| Grade 1-vs-Grade 3 |
2.624000E-02 |
| Grade 1-vs-Grade 4 |
5.756700E-03 |
| Grade 2-vs-Grade 3 |
2.131900E-02 |
| Grade 2-vs-Grade 4 |
6.371500E-04 |
| Grade 3-vs-Grade 4 |
6.772200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.581800E-01 |
| Normal-vs-ccB subtype |
5.362200E-02 |
| ccA subtype-vs-ccB subtype |
1.207170E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.058300E-02 |
| Normal-vs-N1 |
7.247200E-01 |
| N0-vs-N1 |
6.914800E-01 |
|
|
